Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Methods Mol Biol ; 2153: 253-265, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32840785

RESUMEN

The precise organization of the genome inside the cell nucleus is vital to many cell functions including gene expression, cell division, and DNA repair. Here we describe a method to measure pairing of DNA loci during homologous recombination (HR) at a site-specific double-strand break (DSB) in Saccharomyces cerevisiae. This method utilizes a chromosome tagging system in diploid yeast cells to visualize both the DNA at the break site and the homologous DNA that serves as a repair template. DNA repair products are confirmed in parallel by genomic blot. This visualization method provides insight into the physical contact that occurs between homologous loci during HR and correlates physical interaction with the timing of DNA repair.


Asunto(s)
Cromosomas Fúngicos/genética , Reparación del ADN por Recombinación , Saccharomyces cerevisiae/genética , Núcleo Celular/genética , Emparejamiento Cromosómico , Roturas del ADN de Doble Cadena , Microscopía Fluorescente
2.
Mol Biol Cell ; 30(21): 2620-2625, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31483739

RESUMEN

During S phase in Saccharomyces cerevisiae, chromosomal loci become mobile in response to DNA double-strand breaks both at the break site (local mobility) and throughout the nucleus (global mobility). Increased nuclear exploration is regulated by the recombination machinery and the DNA damage checkpoint and is likely an important aspect of homology search. While mobility in response to DNA damage has been studied extensively in S phase, the response in interphase has not, and the question of whether homologous recombination proceeds to completion in G1 phase remains controversial. Here, we find that global mobility is triggered in G1 phase. As in S phase, global mobility in G1 phase is controlled by the DNA damage checkpoint and the Rad51 recombinase. Interestingly, despite the restriction of Rad52 mediator foci to S phase, Rad51 foci form at high levels in G1 phase. Together, these observations indicate that the recombination and checkpoint machineries promote global mobility in G1 phase, supporting the notion that recombination can occur in interphase diploids.


Asunto(s)
Núcleo Celular/genética , Cromosomas Fúngicos/genética , Daño del ADN , Fase G1/genética , Saccharomyces cerevisiae/genética , Núcleo Celular/metabolismo , Roturas del ADN de Doble Cadena , Reparación del ADN/genética , Recombinación Homóloga , Recombinasa Rad51/genética , Recombinasa Rad51/metabolismo , Proteína Recombinante y Reparadora de ADN Rad52/genética , Proteína Recombinante y Reparadora de ADN Rad52/metabolismo , Fase S/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo
3.
Nucleic Acids Res ; 47(17): 9144-9159, 2019 09 26.
Artículo en Inglés | MEDLINE | ID: mdl-31350889

RESUMEN

The postreplication repair gene, HLTF, is often amplified and overexpressed in cancer. Here we model HLTF dysregulation through the functionally conserved Saccharomyces cerevisiae ortholog, RAD5. Genetic interaction profiling and landscape enrichment analysis of RAD5 overexpression (RAD5OE) reveals requirements for genes involved in recombination, crossover resolution, and DNA replication. While RAD5OE and rad5Δ both cause cisplatin sensitivity and share many genetic interactions, RAD5OE specifically requires crossover resolving genes and drives recombination in a region of repetitive DNA. Remarkably, RAD5OE induced recombination does not require other post-replication repair pathway members, or the PCNA modification sites involved in regulation of this pathway. Instead, the RAD5OE phenotype depends on a conserved domain necessary for binding 3' DNA ends. Analysis of DNA replication intermediates supports a model in which dysregulated Rad5 causes aberrant template switching at replication forks. The direct effect of Rad5 on replication forks in vivo, increased recombination, and cisplatin sensitivity predicts similar consequences for dysregulated HLTF in cancer.


Asunto(s)
ADN Helicasas/genética , Replicación del ADN/genética , Proteínas de Unión al ADN/genética , Inestabilidad Genómica/genética , Recombinación Genética/genética , Proteínas de Saccharomyces cerevisiae/genética , Factores de Transcripción/genética , Cisplatino/farmacología , Intercambio Genético/genética , Daño del ADN/efectos de los fármacos , Reparación del ADN/genética , Replicación del ADN/efectos de los fármacos , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Humanos , Neoplasias/genética , Saccharomyces cerevisiae/genética
4.
Genes Dev ; 32(17-18): 1242-1251, 2018 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-30181361

RESUMEN

During homologous recombination, cells must coordinate repair, DNA damage checkpoint signaling, and movement of chromosomal loci to facilitate homology search. In Saccharomyces cerevisiae, increased movement of damaged loci (local mobility) and undamaged loci (global mobility) precedes homolog pairing in mitotic cells. How cells modulate chromosome mobility in response to DNA damage remains unclear. Here, we demonstrate that global chromosome mobility is regulated by the Rad51 recombinase and its mediator, Rad52. Surprisingly, rad51Δ rad52Δ cells display checkpoint-dependent constitutively increased mobility, indicating that a regulatory circuit exists between recombination and checkpoint machineries to govern chromosomal mobility. We found that the requirement for Rad51 in this circuit is distinct from its role in recombination and that interaction with Rad52 is necessary to alleviate inhibition imposed by mediator recruitment to ssDNA. Thus, interplay between recombination factors and the checkpoint restricts increased mobility until recombination proteins are assembled at damaged sites.


Asunto(s)
Cromosomas Fúngicos/metabolismo , Daño del ADN , Recombinación Homóloga , Recombinasa Rad51/fisiología , Proteína Recombinante y Reparadora de ADN Rad52/fisiología , Proteínas de Saccharomyces cerevisiae/fisiología , Mutación , Recombinasa Rad51/genética , Proteína Recombinante y Reparadora de ADN Rad52/genética , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética
5.
Mol Cell ; 67(6): 1068-1079.e4, 2017 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-28890334

RESUMEN

Standard CRISPR-mediated gene disruption strategies rely on Cas9-induced DNA double-strand breaks (DSBs). Here, we show that CRISPR-dependent base editing efficiently inactivates genes by precisely converting four codons (CAA, CAG, CGA, and TGG) into STOP codons without DSB formation. To facilitate gene inactivation by induction of STOP codons (iSTOP), we provide access to a database of over 3.4 million single guide RNAs (sgRNAs) for iSTOP (sgSTOPs) targeting 97%-99% of genes in eight eukaryotic species, and we describe a restriction fragment length polymorphism (RFLP) assay that allows the rapid detection of iSTOP-mediated editing in cell populations and clones. To simplify the selection of sgSTOPs, our resource includes annotations for off-target propensity, percentage of isoforms targeted, prediction of nonsense-mediated decay, and restriction enzymes for RFLP analysis. Additionally, our database includes sgSTOPs that could be employed to precisely model over 32,000 cancer-associated nonsense mutations. Altogether, this work provides a comprehensive resource for DSB-free gene disruption by iSTOP.


Asunto(s)
Proteínas Asociadas a CRISPR/genética , Sistemas CRISPR-Cas , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Codón de Terminación , Edición Génica/métodos , Silenciador del Gen , Animales , Arabidopsis/genética , Arabidopsis/metabolismo , Proteínas Asociadas a CRISPR/metabolismo , Codón sin Sentido , Biología Computacional , Enzimas de Restricción del ADN/genética , Enzimas de Restricción del ADN/metabolismo , Bases de Datos Genéticas , Regulación Fúngica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Regulación de la Expresión Génica de las Plantas , Células HEK293 , Humanos , Ratones , Neoplasias/genética , Neoplasias/metabolismo , Polimorfismo de Longitud del Fragmento de Restricción , ARN Guía de Kinetoplastida/genética , ARN Guía de Kinetoplastida/metabolismo , Ratas , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Transfección
6.
Genetics ; 204(2): 807-819, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27558135

RESUMEN

The CKS1B gene located on chromosome 1q21 is frequently amplified in breast, lung, and liver cancers. CKS1B codes for a conserved regulatory subunit of cyclin-CDK complexes that function at multiple stages of cell cycle progression. We used a high throughput screening protocol to mimic cancer-related overexpression in a library of Saccharomyces cerevisiae mutants to identify genes whose functions become essential only when CKS1 is overexpressed, a synthetic dosage lethal (SDL) interaction. Mutations in multiple genes affecting mitotic entry and mitotic exit are highly enriched in the set of SDL interactions. The interactions between Cks1 and the mitotic entry checkpoint genes require the inhibitory activity of Swe1 on the yeast cyclin-dependent kinase (CDK), Cdc28. In addition, the SDL interactions of overexpressed CKS1 with mutations in the mitotic exit network are suppressed by modulating expression of the CDK inhibitor Sic1. Mutation of the polo-like kinase Cdc5, which functions in both the mitotic entry and mitotic exit pathways, is lethal in combination with overexpressed CKS1 Therefore we investigated the effect of targeting the human Cdc5 ortholog, PLK1, in breast cancers with various expression levels of human CKS1B Growth inhibition by PLK1 knockdown correlates with increased CKS1B expression in published tumor cell data sets, and this correlation was confirmed using shRNAs against PLK1 in tumor cell lines. In addition, we overexpressed CKS1B in multiple cell lines and found increased sensitivity to PLK1 knockdown and PLK1 drug inhibition. Finally, combined inhibition of WEE1 and PLK1 results in less apoptosis than predicted based on an additive model of the individual inhibitors, showing an epistatic interaction and confirming a prediction of the yeast data. Thus, identification of a yeast SDL interaction uncovers conserved genetic interactions that can affect human cancer cell viability.


Asunto(s)
Quinasas CDC2-CDC28/genética , Proteínas de Ciclo Celular/genética , Neoplasias/genética , Proteínas Nucleares/genética , Proteínas Serina-Treonina Quinasas/genética , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Adaptadoras Transductoras de Señales/biosíntesis , Proteínas Adaptadoras Transductoras de Señales/genética , Quinasas CDC2-CDC28/biosíntesis , Proteína Quinasa CDC28 de Saccharomyces cerevisiae/biosíntesis , Proteína Quinasa CDC28 de Saccharomyces cerevisiae/genética , Proteínas de Ciclo Celular/biosíntesis , Línea Celular Tumoral , Secuencia Conservada/genética , Regulación Fúngica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Humanos , Mitosis/genética , Neoplasias/metabolismo , Proteínas Nucleares/biosíntesis , Mapeo de Interacción de Proteínas , Proteínas Serina-Treonina Quinasas/biosíntesis , Proteínas Tirosina Quinasas/biosíntesis , Proteínas Proto-Oncogénicas/biosíntesis , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/biosíntesis , Proteínas de Saccharomyces cerevisiae/genética , Mutaciones Letales Sintéticas/genética , Quinasa Tipo Polo 1
7.
J Emerg Med ; 46(2): 264-70, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24286714

RESUMEN

BACKGROUND: Emergency department (ED) providers commonly care for seriously ill patients who suffer from advanced, chronic, life-limiting illnesses in addition to those that are acutely ill or injured. Both the chronically ill and those who present in extremis may benefit from application of palliative care principles. CASE REPORT: We present a case highlighting the opportunities and need for better integration of emergency medicine and palliative care. DISCUSSION: We offer practical guidelines to the ED faculty/administrators who seek to enhance the quality of patient care in their own unique ED setting by starting an initiative that better integrates palliative principles into daily practice. Specifically, we outline four things to do to jumpstart this collaborative effort. CONCLUSION: The Improving Palliative Care in Emergency Medicine project sponsored by the Center to Advance Palliative Care is a resource that assists ED health care providers with the process and structure needed to integrate palliative care into the ED setting.


Asunto(s)
Prestación Integrada de Atención de Salud/organización & administración , Servicio de Urgencia en Hospital/organización & administración , Cuidados Paliativos/organización & administración , Humanos , Guías de Práctica Clínica como Asunto
8.
Acad Emerg Med ; 19(4): 461-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22506951

RESUMEN

The recent enactment of the Patient Protection and Affordable Care Act (ACA) of 2010, and the ongoing debate over reform of the U.S. health care system, raise numerous important ethical issues. This article reviews basic provisions of the ACA; examines underlying moral and policy issues in the U.S. health care reform debate; and addresses health care reform's likely effects on access to care, emergency department (ED) crowding, and end-of-life care. The article concludes with several suggested actions that emergency physicians (EPs) should take to contribute to the success of health care reform in America.


Asunto(s)
Medicina de Emergencia/ética , Reforma de la Atención de Salud/ética , Códigos de Ética , Aglomeración , Accesibilidad a los Servicios de Salud/ética , Humanos , Principios Morales , Patient Protection and Affordable Care Act , Cuidado Terminal/ética , Estados Unidos
9.
J Emerg Med ; 42(6): e133-5, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19682823

RESUMEN

BACKGROUND: Arteriovenous malformation (AVM) of the scrotum has, to our knowledge, been reported fewer than 10 times in the medical literature. It may be of congenital or post-traumatic etiology and has been reported to present with spontaneous bleeding. CASE REPORT: A case of a spontaneously bleeding scrotal AVM that developed after remote trauma is presented. The differential diagnosis of a scrotal vascular lesion includes varicocele, hemangioma, lymphangioma, and AVM. Although ultrasound and magnetic resonance imaging play an important role in the evaluation, angiography is essential to fully delineate the feeder vessels, vascular takeoffs, and draining veins. CONCLUSION: Scrotal AVMs are rare vascular scrotal lesions that may present with scrotal enlargement and a bruit. Definitive therapy should be planned in concert with Interventional Radiology and surgical consultants.


Asunto(s)
Malformaciones Arteriovenosas/complicaciones , Enfermedades de los Genitales Masculinos/etiología , Hemorragia/etiología , Escroto/irrigación sanguínea , Adulto , Diagnóstico Diferencial , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...